Medical Tourism Market

The Medical Tourism Market is rising awareness about medical tourism among patients is driving in the market. Furthermore, the low cost of medical treatment in developing countries is boosting the growth of the market. Additionally, with patient follow-up and post-surgery complications and quality, safety, and ethical concerns are restraining the growth of the market. However, expansion of telemedicine and virtual consultations, and cross-border collaborations and hospital partnerships will provide growth opportunities for the market in the future.

• Fortis Healthcare has expanded advanced surgical programs and international patient care units, supported by partnerships with global insurance providers and wellness facilitators. In recent initiatives, Fortis reported a 15–18% increase in international patient inflow, driven by collaborative care models and telemedicine integration. Strategic alliances with overseas facilitators strengthened multi-specialty treatment accessibility across cardiac, oncology, and orthopedic services.

Another important dimension is the influence of wellness tourism and lifestyle-driven healthcare. Patients are increasingly aware of packages that combine medical treatments with holistic wellness experiences such as Ayurveda in India, spa therapy in Thailand, or advanced diagnostics at European longevity clinics.

The integration of preventive, curative, and rejuvenating healthcare creates additional appeal for a diverse group of patients. the rise in patient awareness about medical tourism reflects a shift towards more informed, cost-conscious, and quality-driven healthcare decision-making. With easy access to global medical information, transparent service offerings, and supportive government initiatives, awareness will continue to fuel the growth and mainstream adoption of medical tourism worldwide.

• Apollo Hospitals continues expanding its global healthcare footprint through acquisitions and new specialty centers. The group reported over 70% occupancy in international patient wards across major Indian cities. Recent regulatory approvals for advanced robotic surgery and precision oncology programs enhanced treatment credibility. Strategic acquisitions in diagnostic chains further improved cross-border referral efficiency and global patient engagement networks.

The low cost of medical treatment in developing countries has emerged as one of the most powerful drivers of medical tourism market, encouraging patients from developed nations to seek care abroad where healthcare services are available at a fraction of the cost while maintaining comparable quality. 
 
In countries such as India, Thailand, Malaysia, Mexico, Turkey, and the Philippines, advanced medical procedures including cardiac surgery, orthopedic interventions, cosmetic enhancements, fertility treatments, and dental care—can cost 50–80% less than in the United States, Canada, or Western Europe, even after accounting for travel, accommodation, and additional expenses.

• World Bank health expenditure data highlights that average healthcare spending per capita in developing nations such as India and Thailand remains under USD 300–500, compared to over USD 10,000 in the United States. This significant cost gap of nearly 70–80% lower treatment expenses continues to attract millions of patients seeking affordable, high-quality surgical and specialized medical care abroad.

 
This cost advantage is largely driven by lower labor costs, favorable currency exchange rates, and reduced administrative and insurance overheads in developing economies, allowing hospitals to deliver affordable yet high-quality care supported by internationally trained doctors and modern infrastructure.
 
Patients facing exorbitant costs or lack of insurance coverage in their home countries often find medical tourism a practical and attractive alternative, especially for elective or non-emergency procedures that can be planned in advance.
 
In September 2025, Fortis Healthcare launched a 200-bed multispecialty hospital in Greater Noida, strategically located near the upcoming Jewar International Airport. This proximity is expected to significantly boost cross-border patient inflow, making advanced healthcare more accessible to international travelers. By combining modern infrastructure with improved connectivity, the facility is poised to strengthen India’s position as a leading medical tourism destination.

North America: Expanding domestic healthcare costs

The North America medical tourism market has shifted rapidly in responses to continuously high domestic healthcare costs, insurance gaps, and challenges to timely access.  Mexico has emerged as a popular destination for Americans seeking lower-cost dental and cosmetic services, both to geographic proximity and government efforts to promote health travel.

• CDC healthcare utilization data shows over 60% of U.S. adults delay or avoid treatment due to high costs, reinforcing outbound medical tourism demand. GE Healthcare reports a 35% increase in cross-border imaging and diagnostic equipment usage, supporting international patient referrals. These factors strengthen Mexico and nearby destinations as preferred cost-effective treatment hubs for North American patients.

In contrast, the United States, despite being an appealing location for medical tourists, attracts inbound patients seeking highly specialized care in oncology, cardiology, and advanced surgeries, offered by world-class facilities. Anecdotal evidence suggests that a retired US couple flew to Thailand, Vietnam, Mexico, and the Caribbean for cancer treatment for a cost of USD 18,807, saving almost USD 100,000 compared to US prices and bypassing Medicare constraints. A US patient chose a USD 4,000 hysterectomy in Colombia over a USD 15,000 to USD 40,000 treatment in the US.

Europe: Production healthcare systems

Europe medical tourism market accounted for USD 7,733.00 million in 2024 and is projected to grow at a CAGR of 15.88% during the forecast period. Europe is further segmented into the Germany, France, UK, Russia, Italy, Spain, and Rest of the Europe. Medical tourism has grown in prominence throughout Europe as patients seek more timely and cost-effective treatments in the midst of burdened home healthcare systems and long waiting lists.

• European Medicines Agency approvals indicate over 150+ advanced therapies authorized in the past decade, improving treatment availability across EU hospitals. Combined with healthcare system pressure, countries like Germany and Spain report waiting time reductions of up to 40% through cross-border patient programs, driving outbound and intra-Europe medical tourism for faster access to specialized procedures.

In the UK, post-COVID, the outflow began to accelerate. By 2022, around 350,000 UK residents traveled abroad for procedures (hip, knee replacements, cataracts, cardiology), up from around 248,000 in 2019, pushed mostly by overburdened NHS waiting times. Clinics in Lithuania, Poland, Croatia, and France are increasingly catering to these patients, providing faster access at reduced costs. A Highland patient's hip replacement in Poland, for instance, cost about half as much as private care in the UK.

Asia Pacific: Rising healthcare expenses

The Asia-Pacific medical tourism market has been strongly influenced by rising healthcare expenses in Western countries, the development of technologically advanced medical infrastructure throughout Asia, and increased consumer awareness of cross-border treatment choices. Since 2019, Thailand, India, Malaysia, and South Korea have attracted millions of patients each year seeking high-quality, low-cost medical operations ranging from cardiac surgery and orthopedics to cosmetic enhancements and fertility treatments.

Thailand's combination of refined wellness with therapeutic services has made it a top destination, particularly for cosmetic and gender-affirming procedures.

• Malaysia, which had over 1.22 million medical tourists in 2019, has emerged as a destination for cardiology, fertility, cancer, and dental treatments, with specialized patient centers and regional offices.  Thailand, a long-standing leader in the region, continues to draw international patients for cosmetic, wellness, and regenerative therapies, supported by world-class facilities and tourism integration.

Rest of the World: Growing strategic infrastructure investments

The Rest of the World medical tourism market has seen significant transformation, owing to a combination of strategic infrastructure investments, government initiatives, and growing patient flows. In the Middle East, the United Arab Emirates, particularly Dubai and Abu Dhabi, have established themselves as a leading worldwide healthcare destination.

• In 2023, Dubai alone attracted roughly 691,000 medical tourists, who spent approximately AED 1 billion (nearly USD 280 million) on medical treatments. Its popularity arises from a seamless blend of high-end medical facilities, short treatment wait times, opulent recuperation alternatives, and integrated tourist, with platforms such as DXH offering one-stop access to consultations, accommodation, visas, and tourism packages.

Many global, regional, and local vendors characterize the Medical Tourism Market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market.
 
The major players in the market Include Fortis Healthcare, Apollo Hospitals, Bumrungrad International Hospital, Medanta, Bangkok Hospitals, Raffles Medical Group, Asklepios Kliniken GmbH & Co. KGaA strategic market developments and decisions to improve operational effectiveness.